Pulmonary arterial hypertension and right ventricular systolic dysfunction in COVID-19 survivors.
作者信息
Rossi Rosario, Coppi Francesca, Monopoli Daniel Enrique, Sgura Fabio Alfredo, Arrotti Salvatore, Boriani Giuseppe
机构信息
Division of Cardiology, University of Modena and Reggio Emilia (UNIMORE), Modena, Italy.
Pulmonary Hypertension Program, Azienda Ospedaliera Policlinico di Modena, Modena, Italy.
出版信息
Cardiol J. 2022;29(1):163-165. doi: 10.5603/CJ.a2021.0159. Epub 2021 Dec 13.
Abstract
摘要
相似文献
1
Pulmonary arterial hypertension and right ventricular systolic dysfunction in COVID-19 survivors.新冠病毒疾病康复者的肺动脉高压和右心室收缩功能障碍
Cardiol J. 2022;29(1):163-165. doi: 10.5603/CJ.a2021.0159. Epub 2021 Dec 13.
2
Right Ventricular Function After Pulmonary Artery Banding: Adaptive Processes Assessed by CMR and Conductance Catheter Measurements in Sheep.肺动脉环缩术后右心室功能：绵羊 CMＲ 和导丝测量评估的适应性过程。
J Cardiovasc Transl Res. 2019 Oct;12(5):459-466. doi: 10.1007/s12265-019-09881-6. Epub 2019 Mar 7.
3
Update in Pulmonary Vascular Diseases and Right Ventricular Dysfunction 2019.2019年肺血管疾病与右心室功能障碍的进展
Am J Respir Crit Care Med. 2020 Jul 1;202(1):22-28. doi: 10.1164/rccm.202003-0576UP.
4
Risk Prediction and Right Ventricular Dilation in a Single-Institution Pulmonary Arterial Hypertension Cohort.单中心肺动脉高压队列中的风险预测与右心室扩张
J Am Heart Assoc. 2022 Jul 19;11(14):e025521. doi: 10.1161/JAHA.122.025521. Epub 2022 Jul 13.
5
Pulmonary vascular mechanical consequences of ischemic heart failure and implications for right ventricular function.缺血性心力衰竭的肺血管机械性后果及其对右心室功能的影响。
Am J Physiol Heart Circ Physiol. 2019 May 1;316(5):H1167-H1177. doi: 10.1152/ajpheart.00319.2018. Epub 2019 Feb 15.
6
Pulmonary Arterial Hypertension.肺动脉高压
N Engl J Med. 2021 Dec 16;385(25):2361-2376. doi: 10.1056/NEJMra2000348.
7
An easy method for monitoring patients with pulmonary Hypertension: P-wave dispersion.一种监测肺动脉高压患者的简便方法：P波离散度。
Cardiovasc J Afr. 2020 Mar/Apr;31(4):75-80. doi: 10.5830/CVJA-2019-053. Epub 2019 Sep 20.
8
The importance of right ventricular remodelling in pulmonary arterial hypertension.右心室重塑在肺动脉高压中的重要性。
Heart. 2022 Aug 11;108(17):1338-1339. doi: 10.1136/heartjnl-2022-321143.
9
Pulmonary thrombosis in Covid-19: before, during and after hospital admission.新冠病毒肺炎中的肺血栓形成：入院前、住院期间及出院后
J Thromb Thrombolysis. 2021 May;51(4):978-984. doi: 10.1007/s11239-020-02370-7. Epub 2021 Jan 1.
10
Excitation-contraction coupling and relaxation alteration in right ventricular remodelling caused by pulmonary arterial hypertension.肺动脉高压导致右心室重构中的兴奋-收缩偶联和舒张改变。
Arch Cardiovasc Dis. 2020 Jan;113(1):70-84. doi: 10.1016/j.acvd.2019.10.009. Epub 2020 Jan 8.
引用本文的文献
1
Unmasking an Intracardiac Shunt in a Case of Persistent Unexplained Hypoxia: A Case Report.隐匿性心内分流导致持续不明原因低氧血症一例：病例报告
Reports (MDPI). 2025 Jan 26;8(1):16. doi: 10.3390/reports8010016.
2
Gender-Specific Differences in Diastolic Dysfunction and HFpEF: Pathophysiology, Diagnosis, and Therapeutic Strategies.舒张功能障碍和射血分数保留的心力衰竭中的性别差异：病理生理学、诊断和治疗策略。
J Cardiovasc Dev Dis. 2025 Jun 5;12(6):213. doi: 10.3390/jcdd12060213.
3
The Role of Age and Comorbidity Interactions in COVID-19 Mortality: Insights from Cardiac and Pulmonary Conditions.年龄与合并症相互作用在新冠病毒疾病死亡中的作用：来自心脏和肺部疾病的见解
J Clin Med. 2024 Dec 10;13(24):7510. doi: 10.3390/jcm13247510.
4
The predictive role of the TAPSE/sPAP ratio for cardiovascular events and mortality in systemic sclerosis with pulmonary hypertension.TAPSE/sPAP比值对系统性硬化症合并肺动脉高压患者心血管事件和死亡率的预测作用。
Front Cardiovasc Med. 2024 Oct 14;11:1430903. doi: 10.3389/fcvm.2024.1430903. eCollection 2024.
5
A Novel Facet of In-Hospital Food Consumption Associated with Hospital Mortality in Patients with Scheduled Admission-Addition of a Study Protocol to Test the Existence of Effects of COVID-19 in the Same Study in the Post-COVID-19 Period.一种与计划性住院患者院内死亡相关的新的住院期间食物消费模式-在 COVID-19 后时期同一研究中加入研究方案以检验 COVID-19 影响存在性的研究方案。
Nutrients. 2024 Jul 19;16(14):2327. doi: 10.3390/nu16142327.
6
Predictors of Mortality in Pulmonary Hypertension-Associated Chronic Lung Disease.肺动脉高压相关性慢性肺病患者死亡的预测因素
J Clin Med. 2024 Jun 14;13(12):3472. doi: 10.3390/jcm13123472.
7
Mechanisms of Pulmonary Vasculopathy in Acute and Long-Term COVID-19: A Review.急性和长期 COVID-19 中的肺血管病机制：综述。
Int J Mol Sci. 2024 Apr 30;25(9):4941. doi: 10.3390/ijms25094941.
8
Pulmonary Hypertension in Underrepresented Minorities: A Narrative Review.少数族裔中的肺动脉高压：一篇叙述性综述。
J Clin Med. 2024 Jan 4;13(1):285. doi: 10.3390/jcm13010285.
9
Case Report: Two Case Reports of Pulmonary Hypertension after mRNA COVID-19 Vaccination.病例报告：两例mRNA新冠疫苗接种后发生肺动脉高压的病例报告。
Diseases. 2023 Sep 4;11(3):114. doi: 10.3390/diseases11030114.
10
Efficacy of Sildenafil in Patients with Severe COVID-19 and Pulmonary Arterial Hypertension.西地那非治疗重症 COVID-19 合并肺动脉高压患者的疗效。
Viruses. 2023 May 11;15(5):1157. doi: 10.3390/v15051157.
本文引用的文献
1
What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? A harmonised, global longitudinal observational study protocol.新冠感染后康复率及长期后果风险如何？一项全球纵向观察研究的协调方案。
BMJ Open. 2021 Mar 10;11(3):e043887. doi: 10.1136/bmjopen-2020-043887.
2
Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study.新冠病毒感染后综合征。发生率和危险因素：一项地中海队列研究。
J Infect. 2021 Mar;82(3):378-383. doi: 10.1016/j.jinf.2021.01.004. Epub 2021 Jan 12.
3
Pulmonary Vascular Changes in Acute Respiratory Distress Syndrome due to COVID-19.新型冠状病毒肺炎所致急性呼吸窘迫综合征的肺血管变化
Am J Respir Crit Care Med. 2021 Jan 15;203(2):259-260. doi: 10.1164/rccm.202009-3508LE.
4
Pulmonary Vasculature: A Target for COVID-19.肺血管系统：新冠病毒病的一个靶点
Am J Respir Crit Care Med. 2021 Jan 15;203(2):260-261. doi: 10.1164/rccm.202009-3564LE.
5
Low physical functioning and impaired performance of activities of daily life in COVID-19 patients who survived hospitalisation.COVID-19 患者出院后身体机能下降，日常生活活动能力受损。
Eur Respir J. 2020 Oct 15;56(4). doi: 10.1183/13993003.02096-2020. Print 2020 Oct.
6
Pulmonary Angiopathy in Severe COVID-19: Physiologic, Imaging, and Hematologic Observations.严重 COVID-19 中的肺血管病：生理学、影像学和血液学观察。
Am J Respir Crit Care Med. 2020 Sep 1;202(5):690-699. doi: 10.1164/rccm.202004-1412OC.
7
Right Heart Failure: A Hemodynamic Review.右心衰竭：血流动力学综述。
Cardiol Clin. 2020 May;38(2):161-173. doi: 10.1016/j.ccl.2020.01.001. Epub 2020 Feb 20.
8
An overview of the 6th World Symposium on Pulmonary Hypertension.第六届世界肺动脉高压研讨会综述。
Eur Respir J. 2019 Jan 24;53(1). doi: 10.1183/13993003.02148-2018. Print 2019 Jan.
9
Load Adaptability in Patients With Pulmonary Arterial Hypertension.肺动脉高压患者的负荷适应性
Am J Cardiol. 2017 Sep 1;120(5):874-882. doi: 10.1016/j.amjcard.2017.05.053. Epub 2017 Jun 16.
10
Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology.右心对肺动脉高压的适应：生理学和病理生物学。
J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D22-33. doi: 10.1016/j.jacc.2013.10.027.
Zotero 插件